Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Pfizer Us Pharmaceutical Group

Pfizer Us Pharmaceutical Group Recalls

All product recalls associated with Pfizer Us Pharmaceutical Group.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 3921–3940 of 4747 recalls

Effexor XR (Pfizer) – foreign tablet risk (2014)

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Class IHigh

FDAMar 6, 2014Nationwide• Pfizer Us Pharmaceutical Group

Duloxetine Capsules (Teva) – specification failure (2014)

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA

Duloxetine Capsules (Teva) – specification failure (2014)

1...195 196197198 199...238

Page 197 of 238Next

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA

Duloxetine Capsules (Teva) – specification failure (2014)

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA

Zoledronic Acid Injection (Sagent) – sterility concerns (2014)

Lack of Assurance of Sterility; leaking of premix bags

Class IIModerate

FDAMar 4, 2014Nationwide• Sagent Pharmaceuticals Inc

Ritalin HCl (Novartis) – incorrect package insert (2014)

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Class IIILow

FDAMar 3, 2014Nationwide• Novartis Pharmaceuticals Corp.

Ritalin HCl (Novartis) – Incorrect Package Insert (2014)

Class IIILow

FDAMar 3, 2014Nationwide• Novartis Pharmaceuticals Corp.

Advil PM Caplets (Pfizer) – Subpotent Diphenhydramine (2014)

Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Class IIILow

FDAFeb 26, 2014Nationwide• Pfizer Us Pharmaceutical Group

Tom Yom Soup (Whole Foods) – Undeclared Milk (2014)

Ready to eat soup lists whey in the ingredient statement, but the product does not declare milk as the source for the allergen.

Class IHigh

FDAFeb 19, 2014KY, MD, NJ +4 more• Whole Foods Market Mid-Atlantic Kitchen

Fluoxetine Capsules (Legacy) – Chemical Contamination (2014)

Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.

Class IIModerate

FDAFeb 14, 2014Nationwide• Legacy Pharmaceutical Packaging

Daytrana 20mg Patch (Noven) – Delivery System Defect (2014)

Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

Class IIModerate

FDAFeb 13, 2014Nationwide• Noven Pharmaceuticals, Inc.

Daytrana 30mg Patch (Noven) – Delivery System Defect (2014)

Class IIModerate

FDAFeb 13, 2014Nationwide• Noven Pharmaceuticals, Inc.

Fluoxetine 20mg Capsules (Teva) – Odor Contamination (2014)

Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

Class IIModerate

FDAFeb 12, 2014Nationwide• Teva Pharmaceuticals USA

Fluoxetine 10mg Capsules (Teva) – Odor Contamination (2014)

Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

Class IIModerate

FDAFeb 12, 2014Nationwide• Teva Pharmaceuticals USA

QVAR Inhalation Aerosol (Teva) – Impurity Specification (2014)

Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point

Class IIILow

FDAFeb 11, 2014Nationwide• Teva Pharmaceuticals USA